InsidersTradesSigma
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
无可用的信号评分。
Explore the full record of transactions filed by Berenson Stephen, 董事. Director active across 1 company, notably Moderna, Inc.. Cumulatively, 4 reports have been logged. History available since 28 April 2022. The latest transaction was disclosed on 28 April 2022 (Levée d'options). Regulator: SEC (Form 4). All data is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
4 条申报中的 4 条
Stephen Berenson is a Board Member at Moderna, Inc. As a board member, he participates in the governance of the company and provides his expertise to guide strategic decisions. His experience in the biopharmaceutical sector is beneficial for Moderna.